{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T02:17:18Z","timestamp":1772072238139,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ejps.2013.12.002","type":"journal-article","created":{"date-parts":[[2013,12,14]],"date-time":"2013-12-14T12:30:55Z","timestamp":1387024255000},"page":"28-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Pharmacokinetic interactions between rebamipide and selected nonsteroidal anti-inflammatory drugs in rats"],"prefix":"10.1016","volume":"53","author":[{"given":"Dustin L.","family":"Cooper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Robert C.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarrett E.","family":"Wyatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Harirforoosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2013.12.002_b0005","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1007\/BF02063257","article-title":"Rebamipide, novel prostaglandin-inducer accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer. Comparison with cimetidine","volume":"40","author":"Arakawa","year":"1995","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejps.2013.12.002_b0010","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0041-008X(03)00368-5","article-title":"Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity","volume":"192","author":"Boelsterli","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejps.2013.12.002_b0015","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.clinthera.2009.11.010","article-title":"Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets: a randomized, single-dose, two-period, two-sequence crossover study in healthy Korean male volunteers","volume":"31","author":"Cho","year":"2009","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejps.2013.12.002_b0020","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2013.12.002_b0025","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3748\/wjg.v18.i10.1059","article-title":"Rebamipide suppresses diclofenac-induced intestinal permeability via mitochondrial protection in mice","volume":"18","author":"Diao","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejps.2013.12.002_b0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2125.2009.03572.x","article-title":"Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction","volume":"69","author":"Fang","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2013.12.002_b0035","series-title":"Pharmacokinetics","author":"Gibaldi","year":"1982"},{"key":"10.1016\/j.ejps.2013.12.002_b0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1098-3597(01)90069-9","article-title":"Understanding NSAIDs: from aspirin to COX-2","volume":"3","author":"Green","year":"2001","journal-title":"Clin. Cornerstone"},{"key":"10.1016\/j.ejps.2013.12.002_b0045","first-page":"1","article-title":"Pharmacokinetics of celecoxib in the presence and absence of interferon-induced acute inflammation in the rat: applications of a novel HPLC assay","author":"Guirguis","year":"2001","journal-title":"J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.ejps.2013.12.002_b0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1139\/y04-129","article-title":"Effect of nonsteroidal anti-inflammatory drugs with varying extent of COX-2-COX-1 selectivity on urinary sodium and potassium excretion in the rat","volume":"83","author":"Harirforoosh","year":"2005","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejps.2013.12.002_b0055","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1517\/14740330903311023","article-title":"Renal adverse effects of nonsteroidal anti-inflammatory drugs","volume":"8","author":"Harirforoosh","year":"2009","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.ejps.2013.12.002_b0060","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.3748\/wjg.14.4928","article-title":"Permeabilities of rebamipide via rat intestinal membranes and its colon specific delivery using chitosan capsule as a carrier","volume":"14","author":"Huang","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejps.2013.12.002_b0065","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.bcp.2010.01.030","article-title":"Protective effect of rebamipide against celecoxib-induced gastric mucosal cell apoptosis","volume":"79","author":"Ishihara","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2013.12.002_b0070","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1081\/JLC-120038778","article-title":"Determination of rebamipide in human plasma by HPLC","volume":"27","author":"Jeoung","year":"2004","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.ejps.2013.12.002_b0075","first-page":"352","article-title":"A comparison of gastrointestinal permeability induced by diclofenac-phospholipid complex with diclofenac acid and its sodium salt","volume":"6","author":"Khazaeinia","year":"2003","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejps.2013.12.002_b0080","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1007\/s10620-006-9367-y","article-title":"Preventive effects of rebamipide on NSAID-induced gastric mucosal injury and reduction of gastric mucosal blood flow in healthy volunteers","volume":"52","author":"Kim","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejps.2013.12.002_b0085","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/00498250210130591","article-title":"Involvement of cytochrome P450 in the metabolism of rebamipide by the human liver","volume":"32","author":"Koyama","year":"2002","journal-title":"Xenobiotica; Fate Foreign Compd. Biological Syst."},{"key":"10.1016\/j.ejps.2013.12.002_b0090","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.3748\/wjg.v17.i46.5117","article-title":"Aspirin-induced small bowel injuries and the preventive effect of rebamipide","volume":"17","author":"Mizukami","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejps.2013.12.002_b0095","first-page":"727","article-title":"A rapid and sensitive hihg performance liquid chromatographic method for the determination of diclofenac sodium in serum and its use in pharmacokinetic studies, communications","author":"Mohamed","year":"1988","journal-title":"J. Pharm. Parmacol."},{"key":"10.1016\/j.ejps.2013.12.002_b0100","first-page":"137","article-title":"Rebamipide attenuates nonsteroidal anti-inflammatory drugs (NSAID) induced lipid peroxidation by the manganese superoxide dismutase (MnSOD) overexpression in gastrointestinal epithelial cells","volume":"63","author":"Nagano","year":"2012","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejps.2013.12.002_b0105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1586\/egh.10.25","article-title":"Rebamipide: a gastrointestinal protective drug with pleiotropic activities","volume":"4","author":"Naito","year":"2010","journal-title":"Expert Rev. Gastroenterol. Hepat."},{"key":"10.1016\/j.ejps.2013.12.002_b0110","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1124\/dmd.106.012633","article-title":"Mechanism-based inactivation of human cytochrome p450 enzymes and the prediction of drug-drug interactions","volume":"35","author":"Obach","year":"2007","journal-title":"Drug Metab. Dispos.: Biol. Fate Chem."},{"key":"10.1016\/j.ejps.2013.12.002_b0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/03009747809097212","article-title":"Pharmacokinetics and metabolism of the anti-inflammatory agent Voltaren","author":"Riess","year":"1978","journal-title":"Scand. J. Rheumatol. Suppl."},{"key":"10.1016\/j.ejps.2013.12.002_b0120","series-title":"Appl. Biopharm. Pharmacokinet.","author":"Shargel","year":"2012"},{"key":"10.1016\/j.ejps.2013.12.002_b0125","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1081\/DDC-200034577","article-title":"Oral absorption and pharmacokinetics of rebamipide and rebamipide lysinate in rats","volume":"30","author":"Shin","year":"2004","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2013.12.002_b0130","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1254\/jphs.FP0071422","article-title":"Prophylactic effect of rebamipide on aspirin-induced gastric lesions and disruption of tight junctional protein zonula occludens-1 distribution","volume":"106","author":"Suzuki","year":"2008","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejps.2013.12.002_b0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3164\/jcbn.10-75","article-title":"Rebamipide, a mucoprotective drug, inhibits NSAIDs-induced gastric mucosal injury: possible involvement of the downregulation of 15-hydroxyprostaglandin dehydrogenase","volume":"48","author":"Tanigawa","year":"2011","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.ejps.2013.12.002_b0140","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1023\/B:DDAS.0000017439.60943.5c","article-title":"Rebamipide activates genes encoding angiogenic growth factors and Cox2 and stimulates angiogenesis: a key to its ulcer healing action?","volume":"49","author":"Tarnawski","year":"2004","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejps.2013.12.002_b0145","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00003088-198308040-00003","article-title":"Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs","volume":"8","author":"Verbeeck","year":"1983","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2013.12.002_b0150","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nrd1851","article-title":"Predicting in vivo drug interactions from in vitro drug discovery data","volume":"4","author":"Wienkers","year":"2005","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.ejps.2013.12.002_b0155","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejphar.2013.10.035","article-title":"Effects of rebamipide on nephrotoxicity associated with selected NSAIDs in rats","volume":"720","author":"Wood","year":"2013","journal-title":"Eur. J. Pharmacol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098713004594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098713004594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T02:22:15Z","timestamp":1538965335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098713004594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":31,"alternative-id":["S0928098713004594"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2013.12.002","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic interactions between rebamipide and selected nonsteroidal anti-inflammatory drugs in rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2013.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}